Proteomic and transcriptomic analyses of retinal pigment epithelial cells exposed to REF-1/TFPI-2.

PURPOSE The authors previously reported a growth-promoting factor, REF-1/TFPI-2, that is specific to retinal pigment epithelial (RPE) cells. The purpose of this study was to determine the genes and proteins of human RPE cells that are altered by exposure to TFPI-2. METHODS Human primary RPE cells were cultured with or without TFPI-2. Cell extracts and isolated RNA were subjected to proteomic and transcriptomic analyses, respectively. Proteins were separated by two-dimensional gel electrophoresis followed by gel staining and ion spray tandem mass spectrometry analyses. Transcriptomic analysis was performed using a DNA microarray to detect 27,868 gene expressions. RESULTS Proteomic analysis revealed c-Myc binding proteins and ribosomal proteins L11 preferentially induced by TFPI-2 in human RPE cells. Transcriptomic analysis detected 10,773 of 33,096 probes in the TFPI-2 treated samples, whereas only 2186 probes were detected in the nontreated samples. Among the genes up-regulated by TFPI-2 at the protein level were c-myc, Mdm2, transcription factor E2F3, retinoblastoma binding protein, and the p21 gene, which is associated with the c-myc binding protein and ribosomal protein L11. CONCLUSIONS The mechanisms by which TFPI-2 promotes the proliferation of RPE cells may be associated with augmented c-myc synthesis and the activation of E2F in the retinoblastoma protein (Rb)/E2F pathway at the G1 phase of the RPE cells. Activation of ribosomal protein L11 and the Mdm2 complex of the p53 pathway may be counterbalanced by the hyperproliferative conditions.

[1]  Z. Park,et al.  Identification of crystallin family proteins in vitreous body in rat endotoxin‐induced uveitis: Involvement of crystallin truncation in uveitis pathogenesis , 2006, Proteomics.

[2]  L. D. Del Priore,et al.  Gene expression profile of cultured adult compared to immortalized human RPE. , 2006, Molecular vision.

[3]  W. Kisiel,et al.  Structure, function and biology of tissue factor pathway inhibitor-2 , 2005, Thrombosis and Haemostasis.

[4]  M. Miyagi,et al.  Peptidyl-Lys Metalloendopeptidase-catalyzed 18O Labeling for Comparative Proteomics , 2005, Molecular & Cellular Proteomics.

[5]  W. Kisiel,et al.  Crystal Structure of Kunitz Domain 1 (KD1) of Tissue Factor Pathway Inhibitor-2 in Complex with Trypsin , 2005, Journal of Biological Chemistry.

[6]  C. Gondi,et al.  Recombinant adeno‐associated virus (rAAV) expressing TFPI‐2 inhibits invasion, angiogenesis and tumor growth in a human glioblastoma cell line , 2005, International journal of cancer.

[7]  M. Walkinshaw,et al.  Antiproliferative activity of olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor , 2005, Cellular and Molecular Life Sciences CMLS.

[8]  E. Lemarié,et al.  Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancer , 2005, British Journal of Cancer.

[9]  Y. Miyagi,et al.  Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma , 2005, Oncogene.

[10]  Erming Tian,et al.  Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy. , 2005, Virology.

[11]  M. Kitagawa,et al.  Enhanced Mdm2 activity inhibits pRB function via ubiquitin‐dependent degradation , 2005, The EMBO journal.

[12]  Masayo Takahashi,et al.  Embryonic Stem Cells: Potential Source for Ocular Repair , 2005, Seminars in ophthalmology.

[13]  M. Dai,et al.  Inhibition of MDM2-mediated p53 Ubiquitination and Degradation by Ribosomal Protein L5* , 2004, Journal of Biological Chemistry.

[14]  W. Kisiel,et al.  Structure-Function Analysis of the Reactive Site in the First Kunitz-type Domain of Human Tissue Factor Pathway Inhibitor-2* , 2004, Journal of Biological Chemistry.

[15]  T. Allio,et al.  Ribosomal Protein L11 Negatively Regulates Oncoprotein MDM2 and Mediates a p53-Dependent Ribosomal-Stress Checkpoint Pathway , 2003, Molecular and Cellular Biology.

[16]  G. Hunninghake,et al.  Hyperoxia Induces Macrophage Cell Cycle Arrest by Adhesion-dependent Induction of p21Cip1 and Activation of the Retinoblastoma Protein* , 2003, Journal of Biological Chemistry.

[17]  K. Srivenugopal,et al.  Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), in human glioma cells , 2003, Oncogene.

[18]  M. Whiteway,et al.  The ERK/MAPK Pathway Regulates the Activity of the Human Tissue Factor Pathway Inhibitor-2 Promoter* , 2003, The Journal of Biological Chemistry.

[19]  M. Miyagi,et al.  Protein Database, Human Retinal Pigment Epithelium* , 2003, Molecular & Cellular Proteomics.

[20]  Rosalie C Sears,et al.  Signaling Networks That Link Cell Proliferation and Cell Fate* , 2002, The Journal of Biological Chemistry.

[21]  E. Appella,et al.  p53 transcriptional activity is essential for p53‐dependent apoptosis following DNA damage , 2000, The EMBO journal.

[22]  J. Harbour,et al.  Rb function in cell-cycle regulation and apoptosis , 2000, Nature Cell Biology.

[23]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[24]  S. Sasayama,et al.  Tissue Factor Pathway Inhibitor-2 Is a Novel Mitogen for Vascular Smooth Muscle Cells* , 1999, The Journal of Biological Chemistry.

[25]  M. Marmor,et al.  The Retinal Pigment Epithelium: Function and Disease , 1998 .

[26]  T. Sakai,et al.  Promoter activation and following induction of the p21/WAF1 gene by flavone is involved in G1 phase arrest in A549 lung adenocarcinoma cells , 1998, FEBS letters.

[27]  Takako Onishi,et al.  AMY‐1, a novel C‐MYC binding protein that stimulates transcription activity of C‐MYC , 1998, Genes to cells : devoted to molecular & cellular mechanisms.

[28]  J. Nevins,et al.  Toward an understanding of the functional complexity of the E2F and retinoblastoma families. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[29]  N. Dyson.  The regulation of E2F by pRB-family proteins. , 1998, Genes & development.

[30]  J. Escribano,et al.  Gene expression of proteases and protease inhibitors in the human ciliary epithelium and ODM-2 cells. , 1997, Experimental eye research.

[31]  W. Kisiel,et al.  Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Pardee,et al.  Cyclin E and cyclin A as candidates for the restriction point protein. , 1993, Cancer research.

[33]  A. Pardee,et al.  A restriction point for control of normal animal cell proliferation. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Shibuya,et al.  Purification, molecular cloning, and expression of a novel growth-promoting factor for retinal pigment epithelial cells, REF-1/TFPI-2. , 2004, Investigative ophthalmology & visual science.

[35]  K. Srivenugopal,et al.  Promoter methylation and silencing of the tissue factor pathway inhibitor-2 (TFPI-2), a gene encoding an inhibitor of matrix metalloproteinases in human glioma cells. , 2003, Oncogene.